Hyundai Pharmaceutical's hair loss treatment 20,000 bottles are recalled

COMPANY / Reporter Kim Jisun / 2023-07-03 05:10:44

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Hyundai Pharmaceutical is collecting the drug after it was reported that the hair loss treatment drug on sale is mixed with dementia treatment.

It is known that the products subject to recall are mixed with dementia treatments. This was revealed through a pharmacist's report. About 20,000 bottles of recalled products are said to have been produced.

The Ministry of Food and Drug Safety and Hyundai Pharmaceutical are announcing the recall of the product in question through the company's website. Separately, the Ministry of Food and Drug Safety is investigating how the incident occurred and whether consumers took it.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

[Exclusive] Samsung Electronics Passes NVIDIA’s HBM3E 12-High Qualification Test, Secures Supply Deal
Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties
뉴스댓글 >

SNS